› $150,000,000 verdict in personal injury case
Widely used osteoporosis drugs designed to prevent bones from breaking may increase the risk of a rare type of thigh fracture, according to the Food and Drug Administration (FDA). The agency notified consumers and health care workers that all bisphosphonates will now carry a new warning about the fractures on their safety labels.
Osteoprosis poses a serious health risk for women. According to Natural News, women have a higher risk of dying from the bone condition than from breast cancer. But the treatment may be just as dangerous.
Fosamax is in a class of drugs called bisphosphonates (also called diphosphonates) that inhibit osteoclast action and the resorption of bone. It is one of the more popular choices for the treatment of osteoporosis. Natural News warns that Fosamax has been shown to increase the risk of ulcers, especially if taken with anti-inflammatory drugs. The publication also questions whether the medication actually strengthens the bone or makes it weaker.
